Malignant peripheral nerve sheath tumor of the vulva: A multimodal treatment approach

Gynecologic Oncology

Volumn 85, Issue 2, 2002, Pages 365-371

  Lambrou, Nicholas C ^a   Mirhashemi, Ramin ^a   Wolfson, Aaron ^a   Thesiger, Paul ^a   Penalver, Manuel ^a  

^a JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; FEMALE; HUMAN; HUMAN TISSUE; MOBILIZATION; MULTIMODALITY CANCER THERAPY; NERVE SHEATH TUMOR; PAIN; PELVIS; PERIPHERAL NERVE TUMOR; PRIORITY JOURNAL; TREATMENT INDICATION; VULVA CANCER;

EID: 0036095499     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6600     Document Type: Article

References (21)

1. Malignancy in neurofibromatosis type 1
2. Long-term follow-up of von Recklinghausen neurofibromatosis survival and malignant neoplasms
3. Malignant peripheral nerve sheath tumors: A clinicopathological study of 120 cases
4. Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis
5. Malignant peripheral nerve sheath tumors: A clinicopathologic study of 28 cases
6. Malignant peripheral nerve sheath tumors of the buttock and lower extremity: A study of 43 cases
7. Malignant peripheral nerve sheath tumors in neurofibromatosis 1
8. Pathology of tumors of the peripheral nerve sheath in type 1 neurofibromatosis
9. Recent applications of immunoperoxidase histochemistry in human neurooncology
10. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of NF1 gene
11. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1
12. Tumour predisposition in mice heterozygous for a targeted mutation in NF1
13. Mouse tumor model for neurofibromatosis type 1
14. TP53 mutations are frequent in malignant NF1 tumors
15. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells
16. Localized extremity soft tissue sarcoma: An analysis of factors affecting survival
17. Neurofibrosarcoma
18. Therapy of malignant schwannomas: Usefulness of an integrated radiologic surgical therapy
19. Evaluation of (18) fluorode-oxyglucose positron emission tomography (18)FDG PET in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1
20. Adjuvant chemotherapy for localized respectable soft-tissue sarcoma of adults: Meta-analysis of individual data
21. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial